STOCK TITAN

Tredegar (TG) CEO Arijit DasGupta discloses stock and option holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Tredegar Corporation insider Arijit DasGupta, who serves as President, Chief Executive Officer and Director, reported his initial ownership of company securities. He beneficially owns 100,991 shares of Tredegar common stock directly and 7,340 shares indirectly through a 401(k) plan. He also holds stock-based awards, including stock appreciation rights on 22,947 and 4,646 shares exercisable through 2027–2028, plus stock options to purchase 14,056 and 41,221 shares at exercise prices of $10.75 and $15.25–$16.37, all reported as directly owned.

Positive

  • None.

Negative

  • None.
Insider DasGupta Arijit
Role See Remarks
Type Security Shares Price Value
holding Stock Appreciation Right -- -- --
holding Stock Appreciation Right -- -- --
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Tredegar Common Stock -- -- --
holding Tredegar Common Stock -- -- --
Holdings After Transaction: Stock Appreciation Right — 22,947 shares (Direct); Stock Option (right to buy) — 14,056 shares (Direct); Tredegar Common Stock — 100,991 shares (Direct); Tredegar Common Stock — 7,340 shares (Indirect, 401(k) Plan)
Footnotes (1)
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
DasGupta Arijit

(Last) (First) (Middle)
1100 BOULDERS PARKWAY

(Street)
RICHMOND VA 23225

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2026
3. Issuer Name and Ticker or Trading Symbol
TREDEGAR CORP [ TG ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Tredegar Common Stock 100,991 D
Tredegar Common Stock 7,340 I 401(k) Plan
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Right 03/20/2023 03/20/2028 Common Stock 22,947 $16.37 D
Stock Appreciation Right 12/22/2022 03/18/2027 Common Stock 4,646 $15.25 D
Stock Option (right to buy) 12/22/2022 03/18/2027 Common Stock 14,056 $10.75 D
Stock Option (right to buy) 03/18/2022 03/18/2027 Common Stock 41,221 $10.75 D
Explanation of Responses:
Remarks:
Exhibit 24 - Power of Attorney President, Chief Executive Officer and Director
/s/ Arijit DasGupta 01/28/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Tredegar (TG) insider Arijit DasGupta report on this Form 3?

Arijit DasGupta reports his initial beneficial ownership in Tredegar. The filing lists his directly and indirectly owned common shares and several stock-based awards, establishing his baseline equity position as President, Chief Executive Officer and Director.

How many Tredegar (TG) common shares does Arijit DasGupta own directly and indirectly?

He reports direct ownership of 100,991 Tredegar common shares and indirect ownership of 7,340 shares. The indirect shares are held through a 401(k) plan, indicating part of his retirement savings is invested in Tredegar stock.

What stock appreciation rights does Arijit DasGupta hold in Tredegar (TG)?

He holds stock appreciation rights tied to 22,947 shares exercisable from March 20, 2023 to March 20, 2028, and 4,646 shares exercisable from December 22, 2022 to March 18, 2027, all with specified exercise prices per the filing.

What stock options are reported for Arijit DasGupta in Tredegar (TG)?

He reports stock options to buy 14,056 Tredegar common shares and another grant for 41,221 shares. Both option series have an exercise price of $10.75 and an expiration date of March 18, 2027, reflecting long-term equity incentives.

What is Arijit DasGupta’s role at Tredegar Corporation (TG)?

The filing identifies Arijit DasGupta as President, Chief Executive Officer and Director of Tredegar. This combination of executive and board responsibilities explains why his equity holdings and awards must be disclosed under Section 16 rules.

Does this Tredegar (TG) Form 3 show any recent insider buying or selling?

No transactions are reported; the entries are coded as holdings. The Form 3 simply establishes DasGupta’s initial beneficial ownership of common stock, stock appreciation rights, and stock options as of January 1, 2026.